Mayer Bethany 4
4 · Astera Labs, Inc. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Astera Labs (ALAB) Director Bethany Mayer Sells 686 Shares
What Happened
- Bethany Mayer, a director of Astera Labs, sold a total of 686 shares (six open-market transactions) on June 24, 2026 for aggregate proceeds of $270,999. The individual reported lots:
- 54 shares at $393.86 — $21,268
- 193 shares at a weighted avg $392.67 — $75,786 (prices ranged ~$392.15–$392.83)
- 99 shares at a weighted avg $391.27 — $38,736 (prices ranged ~$391.13–$391.38)
- 146 shares at a weighted avg $396.49 — $57,888 (prices ranged ~$396.07–$396.84)
- 165 shares at a weighted avg $398.32 — $65,722 (prices ranged ~$398.00–$398.61)
- 29 shares at $399.96 — $11,599
- These were sales (not purchases). Sales are often routine (e.g., diversification or liquidity) and do not by themselves indicate company outlook.
Key Details
- Transaction date: June 24, 2026; Form 4 filed June 26, 2026 (timely).
- Total shares sold: 686; total proceeds: $270,999.
- Several reported prices are weighted averages; the filing provides price ranges per lot and offers to disclose exact breakdowns on request.
- The sales were made pursuant to a Rule 10b5-1 trading plan adopted by Mayer on November 25, 2024.
- One lot (29 shares) is noted as owned directly by The Jantzen/Mayer Family 2002 Trust, of which Mayer is trustee; she disclaims beneficial ownership of those trust shares except to the extent of any pecuniary interest.
- Shares owned after the transaction are not shown in the summary provided here; see the filing for post-transaction ownership details.
Context
- Sales under 10b5-1 plans are pre-arranged and typically considered automatic, reducing their signal about insider sentiment.
- For retail investors, purchases tend to be more informative than routine sales; consider this trade as part of broader insider activity and company fundamentals.
Insider Transaction Report
Form 4
Mayer Bethany
Director
Transactions
- Sale
Common Stock
[F1]2026-06-24$393.86/sh−54$21,268→ 5,890 total - Sale
Common Stock
[F1][F3]2026-06-24$392.67/sh−193$75,786→ 5,944 total - Sale
Common Stock
[F1][F2]2026-06-24$391.27/sh−99$38,736→ 6,137 total - Sale
Common Stock
[F1][F4]2026-06-24$396.49/sh−146$57,888→ 5,744 total - Sale
Common Stock
[F1][F5]2026-06-24$398.32/sh−165$65,722→ 5,579 total - Sale
Common Stock
[F1]2026-06-24$399.96/sh−29$11,599→ 5,550 total
Holdings
- 839(indirect: By Trust)
Common Stock
[F6]
Footnotes (6)
- [F1]The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $391.1300 to $391.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $392.1500 to $392.8300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $396.0700 to $396.8350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $398.0000 to $398.6100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]These shares are owned directly by The Jantzen/Mayer Family 2002 Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of her pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Signature
/s/ Philip Mazzara, Attorney-in-Fact|2026-06-26